Literature DB >> 3110305

Efficacy of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis.

M P Pugsley, D L Dworzack, E A Horowitz, T A Cuevas, W E Sanders, C C Sanders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3110305     DOI： 10.1093/infdis/156.1.211

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

1.  Guidelines for controlling meningococcal disease.

Authors: 
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

Review 2.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  [Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].

Authors:  P Nicolas; J D Cavallo; R Fabre; G Martet
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.

Authors:  S M Smith; R H Eng; F Tecson-Tumang
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

6.  Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers.

Authors:  D L Dworzack; C C Sanders; E A Horowitz; J M Allais; M Sookpranee; W E Sanders; F M Ferraro
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

Review 7.  Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.

Authors: 
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

8.  Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Authors:  Patricia L Winokur; Kathryn Chaloner; Gary V Doern; Jennifer Ferreira; Michael A Apicella
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

9.  Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis.

Authors:  O H Gilja; A Halstensen; A Digranes; H Mylvaganam; A Aksnes; E A Høiby
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.

Authors:  J M Blondeau; Y Yaschuk
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.